iconstar paper   Hepatitis C Articles (HCV)  
Back grey arrow rt.gif
Short Duration (4, 6 weeks) Combination Therapy With Daclatasvir, Asunaprevir, BMS-791325 and Sofosbuvir in Subjects Infected With Chronic Hepatitis-C (FOURward Study)
This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified June 2014 by Bristol-Myers Squibb
Estimated Enrollment: 30
Study Start Date: July 2014
Estimated Study Completion Date: June 2015
  iconpaperstack View Older Articles   Back to Top   www.natap.org